Jason O'Byrne Vir Biotechnology, Inc. (VIR) insider trading activity

VIR Quotes by TradingView

Jason O'Byrne is EVP & Chief Financial Officer of Vir Biotechnology, Inc.. Currently has a direct ownership of 110,701 shares of VIR, which is worth approximately $623,246. The most recent transaction as insider was on Nov 17, 2025, when has been sold 6,799 shares (Common Stock) at a price of $5.56 per share, resulting in proceeds of $37,802. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 111K
3.74% 3M change
47.6% 12M change
Total Value Held $623,246

Jason O'Byrne Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 17 2025
SELL
Open market or private sale
$37,802 $5.56 p/Share
6,799 Reduced 5.79%
110,701 Common Stock
Feb 22 2025
BUY
Grant, award, or other acquisition
-
40,000 Added 25.81%
115,000 Common Stock
Nov 15 2024
BUY
Grant, award, or other acquisition
-
75,000 Added 50.0%
75,000 Common Stock

Also insider at

CRBU
Caribou Biosciences, Inc. Healthcare
Chief Financial Officer
JO

Jason O'Byrne

EVP & Chief Financial Officer
Berkeley, CA

Track Institutional and Insider Activities on VIR

Follow Vir Biotechnology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VIR shares.

Notify only if

Insider Trading

Get notified when an Vir Biotechnology, Inc. insider buys or sells VIR shares.

Notify only if

News

Receive news related to Vir Biotechnology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VIR